Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-16T11:16:13.764Z Has data issue: false hasContentIssue false
  • English
  • Français

Bovine respiratory disease treatment failure: definition and impact

Published online by Cambridge University Press:  08 March 2021

Calvin W. Booker Open the ORCID record for Calvin W. Booker [Opens in a new window]
Calvin W. Booker*
Affiliation:
Feedlot Health Management Services Ltd, Box 140, Okotoks, Alberta, T1S 2A2, Canada
*
Author for correspondence: Calvin W. Booker, Feedlot Health Management Services Ltd, Box 140, Okotoks, Alberta, T1S 2A2, Canada. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Bovine respiratory disease (BRD) treatment failure occurs when animals receiving a treatment regimen for BRD fail to directly return to health, resulting in chronic illness and a requirement for repeated treatments, sale for salvage slaughter, euthanasia or death. BRD treatment failure has both direct and indirect impacts. Direct impacts include costs to manage chronically ill animals, including those associated with BRD relapse treatment; reduced returns from animals sent for salvage slaughter, loss of the initial investment to purchase the animal and feed and other accumulated expenses to death, and costs associated with carcass disposal. Indirect impacts include costs of infrastructure requirements, and negative effects on animal welfare and employee morale.

Keywords

Bovine respiratory diseaseBRDcattleimpactstreatment failure
Type
Special issue: Papers from Bovine Respiratory Disease Symposium
Information
Animal Health Research Reviews , Volume 21 , Issue 2 , December 2020 , pp. 172 - 174
Check for updates
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abutarbush, SM, Schunicht, OC, Wildman, BK, Hannon, SJ, Jim, GK, Ward, TI and Booker, CW (2012) Comparison of enrofloxacin and ceftiofur sodium for the treatment of relapse of undifferentiated fever/bovine respiratory disease in feedlot cattle. Canadian Veterinary Journal 53, 57–62.Google ScholarPubMed
Apley, M (2015) Feedlot pharmaceutical documentation: protocols, prescriptions, and veterinary feed directives. Veterinary Clinics of North America Food Animal Practice 31, 305–315.CrossRefGoogle ScholarPubMed
Avra, TD, Abell, KM, Shane, DD, Theurer, ME, Larson, RL and White, BJ (2017) A retrospective analysis of risk factors associated with bovine respiratory disease treatment failure in feedlot cattle. Journal of Animal Science 95, 1521–1527.Google ScholarPubMed
Schunicht, OC, Booker, CW, Guichon, PT, Jim, GK, Wildman, BK, Pittman, TJ and Perrett, T (2007) An evaluation of the relative efficacy of tulathromycin for the treatment of undifferentiated fever in feedlot calves in Nebraska. Canadian Veterinary Journal 48, 600–606.Google ScholarPubMed
Teale, CJ and Moulin, G (2012) Prudent use guidelines: a review of existing veterinary guidelines. Revue Scientifique et Technique 31, 343–354.CrossRefGoogle ScholarPubMed